Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock

Translational Research

Volumn 156, Issue 5, 2010, Pages 273-281

  How, Ole Jakob ^a   Røsner, Assami ^a   Kildal, Anders B ^a   Stenberg, Thor A ^a   Gjessing, Petter F ^a   Hermansen, Stig E ^a,b   Myrmel, Truls ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; NORADRENALIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; DIASTOLE; DISEASE EXACERBATION; ENERGY TRANSFER; HEART AFTERLOAD; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART RATE; INOTROPISM; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; SYSTEMIC VASCULAR RESISTANCE; SYSTOLE; VENOUS OXYGEN TENSION; VENTRICULOARTERIAL MATCHING;

EID: 77958602813     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.07.011     Document Type: Article

References (37)

1. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J 29 2008 2388 2442
2. E.M. Antman, D.T. Anbe, and P.W. Armstrong ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J Am Coll Cardiol 44 2004 E1 E211
3. M.S. Cuffe, R.M. Califf, and K.F. Adams Jr. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial JAMA 287 2002 1541 1547
4. W.T. Abraham, K.F. Adams, and G.C. Fonarow In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 2005 57 64
5. S. Thackray, J. Easthaugh, N. Freemantle, and J.G. Cleland The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis Eur J Heart Fail 4 2002 515 529
6. G.S. Francis, B. Sharma, and M. Hodges Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse Am Heart J 103 1982 995 1000
7. R.R. Tuttle, and J. Mills Dobutamine: development of a new catecholamine to selectively increase cardiac contractility Circ Res 36 1975 185 196
8. S.F. Vatner, R.J. McRitchie, and E. Braunwald Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs J Clin Invest 53 1974 1265 1273
9. R.F. Cronin, and E.H. Tan The inotropic effect of l-noradrenaline in experimental cardiogenic shock Can J Physiol Pharmacol 43 1965 55 68
10. M. Laks, G. Callis, and H.J. Swan Hemodynamic effects of low doses of norepinephrine in the conscious dog Am J Physiol 220 1971 171 173
11. S.F. Vatner, D.R. Knight, and T.H. Hintze Norepinephrine-induced beta 1-adrenergic peripheral vasodilation in conscious dogs Am J Physiol 249 1985 H49 H56
12. J.R. Stratton, M.A. Pfeifer, and J.B. Halter The hemodynamic effects of sympathetic stimulation combined with parasympathetic blockade in man Circulation 75 1987 922 929
13. S. Jolly, G. Newton, and E. Horlick Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction Am J Cardiol 96 2005 1617 1620
14. C.B. Overgaard, and V. Dzavik Inotropes and vasopressors: review of physiology and clinical use in cardiovascular disease Circulation 118 2008 1047 1056
15. S. Muller, O.J. How, S.E. Hermansen, T.A. Stenberg, G. Sager, and T. Myrmel Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia Crit Care 12 2008 R20
16. D. Nordhaug, T. Steensrud, C. Korvald, E. Aghajani, and T. Myrmel Preserved myocardial energetics in acute ischemic left ventricular failure - studies in an experimental pig model Eur J Cardiothorac Surg 22 2002 135 142
17. D. Burkhoff The conductance method of left ventricular volume estimation. Methodologic limitations put into perspective Circulation 81 1990 703 706
18. I. Mirsky Assessment of diastolic function: suggested methods and future considerations 82 Circulation 69 1984 836 841
19. B.D. De, P. Biston, and J. Devriendt Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 2010 779 789
20. R. Bellomo, and D.D. Giantomasso Noradrenaline and the kidney: friends or foes? Crit Care 5 2001 294 298
21. T. Myrmel, and C. Korvald New aspects of myocardial oxygen consumption. Invited review Scand Cardiovasc J 34 2000 233 241
22. T. Podzuweit, W.F. Lubbe, and L.H. Opie Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs Lancet 1 1976 341 342
23. M. Packer, N. Medina, and M. Yushak Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure Circulation 70 1984 1038 1047 (Pubitemid 15219365)
24. R. DiBianco, R. Shabetai, W. Kostuk, J. Moran, R.C. Schlant, and R. Wright A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure N Engl J Med 320 1989 677 683
25. M. Argenziano, J.M. Chen, and A.F. Choudhri Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent J Thorac Cardiovasc Surg 116 1998 973 980
26. D.W. Landry, and J.A. Oliver The pathogenesis of vasodilatory shock N Engl J Med 345 2001 588 595
27. D.W. Landry, H.R. Levin, and E.M. Gallant Vasopressin deficiency contributes to the vasodilation of septic shock Circulation 95 1997 1122 1125
28. K. Sunagawa, W.L. Maughan, D. Burkhoff, and K. Sagawa Left ventricular interaction with arterial load studied in isolated canine ventricle Am J Physiol 245 1983 H773 H780
29. E. Nevo Constrained optimization of ventricular efficiency in normal and failing hearts Am J Physiol 264 1993 H1292 H1299
30. D.A. Kass Ventricular arterial stiffening: integrating the pathophysiology Hypertension 46 2005 185 193
31. D.A. Kass, and R.P. Kelly Ventriculo-arterial coupling: concepts, assumptions, and applications Ann Biomed Eng 20 1992 41 62
32. E. Aghajani, S. Muller, and K.E. Kjorstad The pressure-volume loop revisited: Is the search for a cardiac contractility index a futile cycle? Shock 25 2006 370 376
33. D.D. Glower, J.A. Spratt, and N.D. Snow Linearity of the Frank-Starling relationship in the intact heart: the concept of preload recruitable stroke work Circulation 71 1985 994 1009
34. A.F. Leite-Moreira, J. Correia-Pinto, and T.C. Gillebert Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction Cardiovasc Res 43 1999 344 353
35. S.G. De Hert, T.C. Gillebert, P.W. Ten Broecke, E. Mertens, I.E. Rodrigus, and A.C. Moulijn Contraction-relaxation coupling and impaired left ventricular performance in coronary surgery patients Anesthesiology 90 1999 748 757
36. R. Ladeiras-Lopes, J. Ferreira-Martins, and A.F. Leite-Moreira Acute neurohumoral modulation of diastolic function Peptides 30 2009 419 425
37. S. Muller, O.J. How, and O. Jakobsen Oxygen-wasting effect of inotropy: is there a need for a new evaluation? An experimental large-animal study using dobutamine and levosimendan Circ Heart Fail 3 2010 277 285